Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
pirfenidone (esbriet) (1 trial)
Fibrosis (Phase 2)
Liver Cirrhosis (Phase 2)
Liver Diseases (Phase 2)
Trials (1 total)
Trial APIs (1 total)